163 related articles for article (PubMed ID: 8667502)
1. Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.
Shireman PK; McCarthy WJ; Pearce WH; Patterson BK; Shively VP; Cipollone M; Tamarina N; Verrusio EN; Kwaan HC
J Vasc Surg; 1996 May; 23(5):810-7; discussion 817-8. PubMed ID: 8667502
[TBL] [Abstract][Full Text] [Related]
2. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
[TBL] [Abstract][Full Text] [Related]
3. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
[TBL] [Abstract][Full Text] [Related]
4. Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.
Schneiderman J; Sawdey MS; Keeton MR; Bordin GM; Bernstein EF; Dilley RB; Loskutoff DJ
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6998-7002. PubMed ID: 1495992
[TBL] [Abstract][Full Text] [Related]
5. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.
Reilly JM; Sicard GA; Lucore CL
J Vasc Surg; 1994 May; 19(5):865-72. PubMed ID: 8170041
[TBL] [Abstract][Full Text] [Related]
6. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Padró T; Emeis JJ; Steins M; Schmid KW; Kienast J
Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):893-902. PubMed ID: 7600121
[TBL] [Abstract][Full Text] [Related]
7. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas.
Defawe OD; Colige A; Lambert CA; Munaut C; Delvenne P; Lapière CM; Limet R; Nusgens BV; Sakalihasan N
Cardiovasc Res; 2003 Oct; 60(1):205-13. PubMed ID: 14522424
[TBL] [Abstract][Full Text] [Related]
8. In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta.
McMillan WD; Patterson BK; Keen RR; Pearce WH
J Vasc Surg; 1995 Sep; 22(3):295-305. PubMed ID: 7674473
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
[TBL] [Abstract][Full Text] [Related]
10. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.
Lupu F; Bergonzelli GE; Heim DA; Cousin E; Genton CY; Bachmann F; Kruithof EK
Arterioscler Thromb; 1993 Jul; 13(7):1090-100. PubMed ID: 7686395
[TBL] [Abstract][Full Text] [Related]
11. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis.
Sawa H; Lundgren C; Sobel BE; Fujii S
J Am Coll Cardiol; 1994 Dec; 24(7):1742-8. PubMed ID: 7963123
[TBL] [Abstract][Full Text] [Related]
12. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.
Dichtl W; Stiko A; Eriksson P; Goncalves I; Calara F; Banfi C; Ares MP; Hamsten A; Nilsson J
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):3025-32. PubMed ID: 10591684
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.
Louwrens HD; Kwaan HC; Pearce WH; Yao JS; Verrusio E
Eur J Vasc Endovasc Surg; 1995 Oct; 10(3):289-93. PubMed ID: 7552526
[TBL] [Abstract][Full Text] [Related]
14. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
15. Combined effect of retinoic acid and basic FGF on PAI-1 gene expression in vascular smooth muscle cells.
Watanabe A; Kurabayashi M; Arai M; Sekiguchi K; Nagai R
Cardiovasc Res; 2001 Jul; 51(1):151-9. PubMed ID: 11399257
[TBL] [Abstract][Full Text] [Related]
16. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
17. A new butadiene derivative, T-686, inhibits plasminogen activator inhibitor type-1 production in vitro by cultured human vascular endothelial cells and development of atherosclerotic lesions in vivo in rabbits.
Vinogradsky B; Bell SP; Woodcock-Mitchell J; Ohtani A; Fujii S
Thromb Res; 1997 Feb; 85(4):305-14. PubMed ID: 9062954
[TBL] [Abstract][Full Text] [Related]
18. Expression of the plasminogen activator system in the human vascular wall.
Salame MY; Samani NJ; Masood I; deBono DP
Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta.
Hamdan AD; Quist WC; Gagne JB; Feener EP
Circulation; 1996 Mar; 93(6):1073-8. PubMed ID: 8653825
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 beta induces differential gene expression in aortic smooth muscle cells.
Keen RR; Nolan KD; Cipollone M; Scott E; Shively VP; Yao JS; Pearce WH
J Vasc Surg; 1994 Nov; 20(5):774-84; discussion 784-6. PubMed ID: 7966813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
